Armata Pharmaceuticals Statistics

Total Valuation

ARMP has a market cap or net worth of $90.48 million. The enterprise value is $225.62 million.

Market Cap	90.48M
Enterprise Value	225.62M

Important Dates

The last earnings date was Tuesday, August 12, 2025, after market close.

Earnings Date	Aug 12, 2025
Ex-Dividend Date	n/a

Share Statistics

ARMP has 36.19 million shares outstanding. The number of shares has increased by 0.19% in one year.

Current Share Class	36.23M
Shares Outstanding	36.19M
Shares Change (YoY)	+0.19%
Shares Change (QoQ)	-39.15%
Owned by Insiders (%)	0.77%
Owned by Institutions (%)	2.13%
Float	10.84M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	13.17
Forward PS	n/a
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	32.85
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.06

Current Ratio	0.06
Quick Ratio	0.05
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-2.60

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-23.35%
Return on Invested Capital (ROIC)	-25.98%
Return on Capital Employed (ROCE)	89.91%
Revenue Per Employee	$114,467
Profits Per Employee	-$428,450
Employee Count	60
Asset Turnover	0.07
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -1.96% in the last 52 weeks. The beta is 1.00, so ARMP's price volatility has been similar to the market average.

Beta (5Y)	1.00
52-Week Price Change	-1.96%
50-Day Moving Average	2.20
200-Day Moving Average	1.99
Relative Strength Index (RSI)	56.36
Average Volume (20 Days)	10,390

Short Selling Information

The latest short interest is 50,466, so 0.14% of the outstanding shares have been sold short.

Short Interest	50,466
Short Previous Month	103,565
Short % of Shares Out	0.14%
Short % of Float	0.47%
Short Ratio (days to cover)	3.48

Income Statement

In the last 12 months, ARMP had revenue of $6.87 million and -$25.71 million in losses. Loss per share was -$1.36.

Revenue	6.87M
Gross Profit	-22.89M
Operating Income	-35.33M
Pretax Income	-79.58M
Net Income	-25.71M
EBITDA	-33.89M
EBIT	-35.33M
Loss Per Share	-$1.36

Full Income Statement

Balance Sheet

The company has $4.33 million in cash and $139.47 million in debt, giving a net cash position of -$135.14 million or -$3.73 per share.

Cash & Cash Equivalents	4.33M
Total Debt	139.47M
Net Cash	-135.14M
Net Cash Per Share	-$3.73
Equity (Book Value)	-69.50M
Book Value Per Share	-1.92
Working Capital	-112.57M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$31.58 million and capital expenditures -$511,000, giving a free cash flow of -$32.09 million.

Operating Cash Flow	-31.58M
Capital Expenditures	-511,000
Free Cash Flow	-32.09M
FCF Per Share	-$0.89

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	-514.40%
Pretax Margin	-374.30%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

ARMP does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.19%
Shareholder Yield	-0.19%
Earnings Yield	-28.41%
FCF Yield	-35.47%

Analyst Forecast

The average price target for ARMP is $9.00, which is 260.00% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$9.00
Price Target Difference	260.00%
Analyst Consensus	Strong Buy
Analyst Count	1
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	2